-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Mycotopia Therapies, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2018 to Q3 2024.
- Mycotopia Therapies, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$385K, a 133% decline year-over-year.
- Mycotopia Therapies, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$1.33M, a 71.3% decline year-over-year.
- Mycotopia Therapies, Inc. annual Operating Income (Loss) for 2023 was -$617K, a 64.5% increase from 2022.
- Mycotopia Therapies, Inc. annual Operating Income (Loss) for 2022 was -$1.74M, a 65.2% increase from 2021.
- Mycotopia Therapies, Inc. annual Operating Income (Loss) for 2021 was -$4.99M, a 34963% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)